drugset / Trial / NCT01427504

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

NCT01427504

Completed 26 enrolled University of Colorado, Denver
RandomizedCrossoverOpen-label

Summary

The investigators believe that boceprevir's drug concentrations will be reduced when administered in combination with etravirine. The investigators believe that etravirine's drug concentrations will be increased when administered in combination with boceprevir. Additionally, the investigators believe that boceprevir and etravirine are safe when administered alone or in combination.

Timeline

Start
2011-08
Primary completion
2011-12
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Boceprevir Small molecule 800 mg
Subject Etravirine Small molecule 200 mg